Henry Memczak
Stanford University School of Medicine, USA
Biography
Henry Memczak studied nanotechnology at the University of Kassel, Germany and completed his PhD in biochemistry in 2014 at the University of Potsdam, Germany and the Fraunhofer Institute for Cell Therapy and Immunology, Germany. He has worked on the development of analytical biosensors for influenza detection and methods for peptide-based biointeraction analysis for several years, published several papers, holds two patents and co-founded the company qpa bioanalytics GmbH for the commercialization of novel peptide biochips. For his dedicated translational research he received several awards and scholarships.